LIFECORE BIOMEDICAL, INC. Total Contract Liability
LIFECORE BIOMEDICAL, INC. (LFCR) had Total Contract Liability of $9.01 million as of 2024-11-24, per its 10-Q filed 2025-01-02.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2025-01-02
- 2024-11-24: Contract with Customer, Liability $9.01M.
- 2024-08-25: Contract with Customer, Liability $9.25M.
- 2024-05-26: Contract with Customer, Liability $10.58M; Contract with Customer, Liability as first filed $7.10M.
- 2024-02-25: Contract with Customer, Liability $3.50M.
| Period end | Contract with Customer, Liability | Contract with Customer, Liability as first filed |
|---|---|---|
| 2024-11-24 | $9.01M 10-Q · filed 2025-01-02 | |
| 2024-08-25 | $9.25M 10-Q · filed 2024-10-04 | |
| 2024-05-26 | $10.58M 10-Q · filed 2025-01-02 | $7.10M 10-K · filed 2024-08-26 |
| 2024-02-25 | $3.50M 10-Q · filed 2024-08-09 | |
| 2023-11-26 | $8.60M 10-Q · filed 2024-08-09 | |
| 2023-08-27 | $10.04M 10-Q · filed 2024-10-04 | $10.00M 10-Q · filed 2024-08-09 |
| 2023-05-28 | $7.00M 10-Q · filed 2024-10-04 | $7.00M 10-K · filed 2024-03-20 |
| 2022-05-29 | $900.00K 10-K · filed 2024-08-26 | |
| 2021-02-28 | $1.10M 10-Q · filed 2021-04-08 | |
| 2020-11-29 | $300.00K 10-Q · filed 2021-01-07 | |
| 2020-08-30 | $0.00 10-Q · filed 2020-10-07 | |
| 2020-05-31 | $0.00 10-Q · filed 2021-04-08 | |
| 2020-02-23 | $300.00K 10-Q · filed 2020-04-03 | |
| 2019-11-24 | $300.00K 10-Q · filed 2020-01-02 | |
| 2019-08-25 | $100.00K 10-Q · filed 2019-10-03 | |
| 2019-05-26 | $200.00K 10-Q · filed 2020-04-03 | |
| 2018-05-27 | $2.60M 10-K · filed 2019-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |